RAPPORT - SFRMS

— 143 —21. Blin P, Olie JP, Sechter D, Petitjean F, Cialdella P, Gerard A, et al. [Neuroleptic drug utilization amongschizophrenic outpatients]. Rev Epidemiol Sante Publique 2005;53:601-13.22. Grolleau A, Cougnard A, Parrot M, Kalmi E, Desage A, Misdrahi D, et al. Pratiques de prescription destraitements antipsychotiques dans les premieres hospitalisations pour épisode psychotique : étude sur unecohorte de patients hospitalisés dans deux hôpitaux girondins. Encephale 2006;sous presse.23. Martin K, Begaud B, Verdoux H, Lechevallier N, Latry P, Moore N. Patterns of risperidone prescription: autilization study in south-west France. Acta Psychiatr Scand 2004;109:202-6.24. Verdoux H, Cougnard A, Grolleau S, Besson R, Delcroix F. How do general practitioners manage subjectswith early schizophrenia and collaborate with mental health professionals? A postal survey in South-WesternFrance. Soc Psychiatry Psychiatr Epidemiol 2005;40:892-8.25. Verdoux H, Cougnard A, Grolleau S, Begaud B. Impact of visits from pharmaceutical companyrepresentatives on antipsychotic prescription in primary care. Schizophr Res 2005;77:107-9.26. Ashcroft DM, Frischer M, Lockett J, Chapman SR. Variations in prescribing atypical antipsychotic drugs inprimary care: cross-sectional study. Pharmacoepidemiol Drug Saf 2002;11:285-9.27. Kaye JA, Bradbury BD, Jick H. Changes in antipsychotic drug prescribing by general practitioners in theUnited Kingdom from 1991 to 2000: a population-based observational study. Br J Clin Pharmacol2003;56:569-75.28. Paterniti S, Bisserbe JC, Alperovitch A. [Psychotropic drugs, anxiety and depression in the elderlypopulation. The EVA study]. Rev Epidemiol Sante Publique 1998;46:253-62.29. Lechevallier-Michel N, Gautier-Bertrand M, Alperovitch A, Berr C, Belmin J, Legrain S, et al. Frequencyand risk factors of potentially inappropriate medication use in a community-dwelling elderly population: resultsfrom the 3C Study. Eur J Clin Pharmacol 2005;60:813-9.30. Fourrier A, Letenneur L, Dartigues JF, Moore N, Begaud B. Benzodiazepine use in an elderly communitydwellingpopulation. Characteristics of users and factors associated with subsequent use. Eur J Clin Pharmacol2001;57:419-25.31. Kopferschmitt J, Meyer P, Jaeger A, Mantz JM, Roos M. [Sleep disorders and use of psychotropic drugs in6-year-old children]. Rev Epidemiol Sante Publique 1992;40:467-71.32. Levy L, Martin-Guehl C, Lechevallier-Michel N, Noize P, Moore N, Latry P, et al. Use of psychotropicdrugs in 0 to 5 years old children in Aquitaine (France): prevalence and associated factors. PharmacoepidemiolDrug Saf 2006.33. Pelissolo A, Notides C, Lepine JP, Bisserbe JC. Anxiolytic and hypnotic use by general hospital inpatients.The impact of psychopathology and general medical conditions. Gen Hosp Psychiatry 1999;21:79-86.34. Schirm E, Tobi H, Zito JM, de Jong-van den Berg LT. Psychotropic medication in children: a study fromthe Netherlands. Pediatrics 2001;108:E25.35. Hugtenburg JG, Heerdink ER, Egberts AC. Increased psychotropic drug consumption by children in theNetherlands during 1995-2001 is caused by increased use of methylphenidate by boys. Eur J Clin Pharmacol2004;60:377-9.36. Jick H, Kaye JA, Black C. Incidence and prevalence of drug-treated attention deficit disorder among boysin the UK. Br J Gen Pract 2004;54:345-7.37. Schmidt-Troschke SO, Ostermann T, Melcher D, Schuster R, Erben CM, Matthiessen PF. [The use ofmethylphenidate in children: analysis of prescription usage based in routine data of the statutory healthinsurance bodies concerning drug prescriptions]. Gesundheitswesen 2004;66:387-92.38. Frances C, Hoizey G, Millart H, Trenque T. Paediatric methylphenidate (Ritalin) restrictive conditions ofprescription in France. Br J Clin Pharmacol 2004;57:115-6.39. Bennett K, Teeling M, Feely J. Overprescribing antidepressants to children: pharmacoepidemiologicalstudy in primary care. BMJ 2005;331:1451-2.40. Murray ML, de Vries CS, Wong IC. A drug utilisation study of antidepressants in children and adolescentsusing the General Practice Research Database. Arch Dis Child 2004;89:1098-102.41. Fegert JM, Kolch M, Zito JM, Glaeske G, Janhsen K. Antidepressant use in children and adolescents inGermany. J Child Adolesc Psychopharmacol 2006;16:197-206.